| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |